OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment
Anne Ducros, Solène de Gaalon, Caroline Roos, et al.
Revue Neurologique (2021) Vol. 177, Iss. 7, pp. 734-752
Closed Access | Times Cited: 53
Anne Ducros, Solène de Gaalon, Caroline Roos, et al.
Revue Neurologique (2021) Vol. 177, Iss. 7, pp. 734-752
Closed Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
Hallmarks of primary headache: part 1 – migraine
Alberto Raggi, Matilde Leonardi, Marco A. Arruda, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 34
Alberto Raggi, Matilde Leonardi, Marco A. Arruda, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 34
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 8
Open Access | Times Cited: 27
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 8
Open Access | Times Cited: 27
Management of chronic migraine
Alexandra Hovaguimian, Julie Roth
BMJ (2022), pp. e067670-e067670
Open Access | Times Cited: 55
Alexandra Hovaguimian, Julie Roth
BMJ (2022), pp. e067670-e067670
Open Access | Times Cited: 55
The sense of stopping migraine prophylaxis
Linda Al‐Hassany, Hannah Lyons, Deirdre M. Boucherie, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 30
Linda Al‐Hassany, Hannah Lyons, Deirdre M. Boucherie, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 30
Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis
William Kristian Karlsson, Edoardo G. Ostinelli, Zixuan Alice Zhuang, et al.
BMJ (2024), pp. e080107-e080107
Closed Access | Times Cited: 16
William Kristian Karlsson, Edoardo G. Ostinelli, Zixuan Alice Zhuang, et al.
BMJ (2024), pp. e080107-e080107
Closed Access | Times Cited: 16
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Migraine management: Non-pharmacological points for patients and health care professionals
Faraidoon Haghdoost, Mansoureh Togha
Open Medicine (2022) Vol. 17, Iss. 1, pp. 1869-1882
Open Access | Times Cited: 33
Faraidoon Haghdoost, Mansoureh Togha
Open Medicine (2022) Vol. 17, Iss. 1, pp. 1869-1882
Open Access | Times Cited: 33
Prescription of therapeutic exercise in migraine, an evidence-based clinical practice guideline
Roy La Touche, José Fierro‐Marrero, Irene Sánchez-Ruíz, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
Roy La Touche, José Fierro‐Marrero, Irene Sánchez-Ruíz, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders
Michał Fila, Jan Chojnacki, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10134-10134
Open Access | Times Cited: 37
Michał Fila, Jan Chojnacki, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10134-10134
Open Access | Times Cited: 37
Long–Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine
Soohyun Cho, Byung‐Kun Kim
Current Pain and Headache Reports (2024) Vol. 28, Iss. 8, pp. 743-751
Closed Access | Times Cited: 6
Soohyun Cho, Byung‐Kun Kim
Current Pain and Headache Reports (2024) Vol. 28, Iss. 8, pp. 743-751
Closed Access | Times Cited: 6
The impact of curcumin on migraine: A comprehensive review
Hajar Heidari, Mehrnaz Shojaei, Gholamreza Askari, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114910-114910
Open Access | Times Cited: 12
Hajar Heidari, Mehrnaz Shojaei, Gholamreza Askari, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114910-114910
Open Access | Times Cited: 12
Chinese medicine for headaches in emergency department: a retrospective analysis of real-world electronic medical records
Zhenhui Mao, Shang‐Heng Wu, Yu Fan, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Zhenhui Mao, Shang‐Heng Wu, Yu Fan, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Acupuncture for the prevention of episodic migraine
Ruyu Xia, Klaus Linde, Tobias Freilinger, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Open Access
Ruyu Xia, Klaus Linde, Tobias Freilinger, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Open Access
Reassessing partial efficacy or not responding to acute migraine treatment
Leyi Yang, Tengyu Jin, Hebo Wang
Cephalalgia (2025) Vol. 45, Iss. 3
Closed Access
Leyi Yang, Tengyu Jin, Hebo Wang
Cephalalgia (2025) Vol. 45, Iss. 3
Closed Access
High-risk area for migraine attacks — a new concept in migraine pathophysiology
Marianna Gabriella Rispoli, Maria Vittoria De Angelis, Donato Melchionda, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Marianna Gabriella Rispoli, Maria Vittoria De Angelis, Donato Melchionda, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Principios de manejo del dolor crónico
G. Guillemet
EMC - Kinesiterapia - Medicina Física (2025) Vol. 46, Iss. 2, pp. 1-13
Closed Access
G. Guillemet
EMC - Kinesiterapia - Medicina Física (2025) Vol. 46, Iss. 2, pp. 1-13
Closed Access
Evidence-based guidelines for the pharmacological treatment of migraine
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access
Principi di gestione di un dolore cronico
G. Guillemet
EMC - Medicina Riabilitativa (2025) Vol. 32, Iss. 2, pp. 1-12
Closed Access
G. Guillemet
EMC - Medicina Riabilitativa (2025) Vol. 32, Iss. 2, pp. 1-12
Closed Access
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
Andreas A. Argyriou, Emmanouil V. Dermitzakis, George S. Vlachos, et al.
Acta Neurologica Scandinavica (2022) Vol. 145, Iss. 6, pp. 676-683
Closed Access | Times Cited: 16
Andreas A. Argyriou, Emmanouil V. Dermitzakis, George S. Vlachos, et al.
Acta Neurologica Scandinavica (2022) Vol. 145, Iss. 6, pp. 676-683
Closed Access | Times Cited: 16
Multiple sclerosis and migraine: Links, management and implications
Saloua Mrabet, Mohamad Wafa, Gavin Giovannoni
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104152-104152
Closed Access | Times Cited: 16
Saloua Mrabet, Mohamad Wafa, Gavin Giovannoni
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104152-104152
Closed Access | Times Cited: 16
Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal
William Wells-Gatnik, Paolo Martelletti
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 9, pp. 777-781
Closed Access | Times Cited: 8
William Wells-Gatnik, Paolo Martelletti
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 9, pp. 777-781
Closed Access | Times Cited: 8
The effectiveness of agomelatine on headache severity and frequency in episodic migraine without aura; a parallel randomized controlled trial study
Kourosh Farzin, Azita Kheiltash, Abbas Tafakhori, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Kourosh Farzin, Azita Kheiltash, Abbas Tafakhori, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial
Lu Liu, Qiuyi Chen, Luopeng Zhao, et al.
Cephalalgia (2024) Vol. 44, Iss. 6
Open Access | Times Cited: 3
Lu Liu, Qiuyi Chen, Luopeng Zhao, et al.
Cephalalgia (2024) Vol. 44, Iss. 6
Open Access | Times Cited: 3
Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment
Geneviève Demarquay, Xavier Moisset, Michel Lantéri‐Minet, et al.
Revue Neurologique (2021) Vol. 177, Iss. 7, pp. 725-733
Closed Access | Times Cited: 20
Geneviève Demarquay, Xavier Moisset, Michel Lantéri‐Minet, et al.
Revue Neurologique (2021) Vol. 177, Iss. 7, pp. 725-733
Closed Access | Times Cited: 20
